- Home
- TCI vs VNDA Comparison
TCI vs VNDA Comparison
Compare TCI & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCI
- VNDA
- Stock Information
- Founded
- TCI 1983
- VNDA 2002
- Country
- TCI United States
- VNDA United States
- Employees
- TCI N/A
- VNDA N/A
- Industry
- TCI Real Estate
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- TCI Finance
- VNDA Health Care
- Exchange
- TCI Nasdaq
- VNDA Nasdaq
- Market Cap
- TCI 240.5M
- VNDA 270.2M
- IPO Year
- TCI N/A
- VNDA 2006
- Fundamental
- Price
- TCI $27.45
- VNDA $5.00
- Analyst Decision
- TCI
- VNDA Strong Buy
- Analyst Count
- TCI 0
- VNDA 2
- Target Price
- TCI N/A
- VNDA $15.50
- AVG Volume (30 Days)
- TCI 2.2K
- VNDA 623.2K
- Earning Date
- TCI 11-07-2024
- VNDA 11-06-2024
- Dividend Yield
- TCI N/A
- VNDA N/A
- EPS Growth
- TCI N/A
- VNDA N/A
- EPS
- TCI 0.37
- VNDA N/A
- Revenue
- TCI $49,821,000.00
- VNDA $190,858,000.00
- Revenue This Year
- TCI N/A
- VNDA $5.13
- Revenue Next Year
- TCI N/A
- VNDA $42.65
- P/E Ratio
- TCI $74.27
- VNDA N/A
- Revenue Growth
- TCI 4.46
- VNDA N/A
- 52 Week Low
- TCI $26.29
- VNDA $3.39
- 52 Week High
- TCI $43.40
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- TCI 45.32
- VNDA 52.22
- Support Level
- TCI $26.29
- VNDA $4.56
- Resistance Level
- TCI $28.09
- VNDA $5.55
- Average True Range (ATR)
- TCI 0.53
- VNDA 0.22
- MACD
- TCI 0.01
- VNDA 0.04
- Stochastic Oscillator
- TCI 53.46
- VNDA 44.44
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.